Kyprolis | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Kyprolis
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

evonik-m-2025-09-08

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Kyprolis

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

48 API Suppliers, 21 USDMF, 5 EU WC, 5 KDMF, 11 NDC API, 25 Listed Suppliers, $ API Reference Price

48 API Suppliers
21 USDMF
5 EU WC
5 KDMF
11 NDC API
25 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

135 Drugs in Development

135 Drugs in Development

INTERMEDIATES

11 Intermediate Suppliers

11 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

55 FDF Dossiers, 13 FDA Orange Book, 7 Europe, 3 Canada, 18 Australia, 1 South Africa, 13 Listed Dossiers

55 FDF Dossiers
13 FDA Orange Book
7 Europe
3 Canada
18 Australia
1 South Africa
13 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 CD Formulation, 1 Gangwal Chemicals

1 CD Formulation
1 Gangwal Chemicals

EXCIPIENTS BY APPLICATIONS

2 Thickeners and Stabilizers, 2 Solubilizers, 1 Dry Powder Inhalation, 1 Parenteral, 1 Fillers, Diluents & Binders, 1 Taste Masking, 1 Emulsifying Agents

2 Thickeners and Stabilizers
2 Solubilizers
1 Dry Powder Inhalation
1 Parenteral
1 Fillers, Diluents & Binders
1 Taste Masking
1 Emulsifying Agents

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 123 News #PharmaBuzz

2 Data Compilation #PharmaFlow
123 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 6 Regulatory FDF Prices, 22 Annual Reports

1 US Medicaid Prescriptions
6 Regulatory FDF Prices
22 Annual Reports

MARKET PLACE

4 APIs, 1 FDF Dossiers

4 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

69 US Patents, 6 US Exclusivities, 18 Health Canada Patents

69 US Patents
6 US Exclusivities
18 Health Canada Patents

$ API Ref.Price (USD/KG) : 371,335 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

18 All

01 18Amgen Canada Inc.

filter Patent Reset all filters

18 All

01 32589765

02 32589921

03 32701778

04 32741312

05 32865950

06 32873044

filter Product Reset all filters

18 All

01 18CARFILZOMIB

filter Dosage Reset all filters

18 All

01 18POWDER FOR SOLUTION

filter Exp Date Reset all filters

18 All

01 32025-08-08

02 32025-12-07

03 32028-10-03

04 32029-10-21

05 32033-02-27

06 32033-05-08

Product Main Page

01

Amgen Canada Inc.

CARFILZOMIB

ChemOutsourcing

Not Confirmed

Amgen Canada Inc.

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-08-08

Date Granted : 2015-06-30

CARFILZOMIB

Brand Name : KYPROLIS

Patent Number : 2589765

Filing Date : 2005-08-08

Strength per Unit : 60 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2025-08-08

Date Granted : 2015-06-30

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Amgen Canada Inc.

CARFILZOMIB

ChemOutsourcing

Not Confirmed

Amgen Canada Inc.

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-12-07

Date Granted : 2016-01-26

CARFILZOMIB

Brand Name : KYPROLIS

Patent Number : 2589921

Filing Date : 2005-12-07

Strength per Unit : 60 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2025-12-07

Date Granted : 2016-01-26

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Amgen Canada Inc.

CARFILZOMIB

ChemOutsourcing

Not Confirmed

Amgen Canada Inc.

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-08-08

Date Granted : 2015-06-30

CARFILZOMIB

Brand Name : KYPROLIS

Patent Number : 2589765

Filing Date : 2005-08-08

Strength per Unit : 10 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2025-08-08

Date Granted : 2015-06-30

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Amgen Canada Inc.

CARFILZOMIB

ChemOutsourcing

Not Confirmed

Amgen Canada Inc.

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-12-07

Date Granted : 2016-01-26

CARFILZOMIB

Brand Name : KYPROLIS

Patent Number : 2589921

Filing Date : 2005-12-07

Strength per Unit : 10 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2025-12-07

Date Granted : 2016-01-26

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Amgen Canada Inc.

CARFILZOMIB

ChemOutsourcing

Not Confirmed

Amgen Canada Inc.

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-12-07

Date Granted : 2016-01-26

CARFILZOMIB

Brand Name : KYPROLIS

Patent Number : 2589921

Filing Date : 2005-12-07

Strength per Unit : 30 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2025-12-07

Date Granted : 2016-01-26

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Amgen Canada Inc.

CARFILZOMIB

ChemOutsourcing

Not Confirmed

Amgen Canada Inc.

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-08-08

Date Granted : 2015-06-30

CARFILZOMIB

Brand Name : KYPROLIS

Patent Number : 2589765

Filing Date : 2005-08-08

Strength per Unit : 30 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2025-08-08

Date Granted : 2015-06-30

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Amgen Canada Inc.

CARFILZOMIB

ChemOutsourcing

Not Confirmed

Amgen Canada Inc.

Country

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-02-27

Date Granted : 2016-12-20

CARFILZOMIB

Brand Name : KYPROLIS

Patent Number : 2865950

Filing Date : 2013-02-27

Strength per Unit : 10 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2033-02-27

Date Granted : 2016-12-20

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

08

Amgen Canada Inc.

CARFILZOMIB

ChemOutsourcing

Not Confirmed

Amgen Canada Inc.

Country

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-02-27

Date Granted : 2016-12-20

CARFILZOMIB

Brand Name : KYPROLIS

Patent Number : 2865950

Filing Date : 2013-02-27

Strength per Unit : 60 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2033-02-27

Date Granted : 2016-12-20

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

09

Amgen Canada Inc.

CARFILZOMIB

ChemOutsourcing

Not Confirmed

Amgen Canada Inc.

Country

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-10-03

Date Granted : 2018-09-11

CARFILZOMIB

Brand Name : KYPROLIS

Patent Number : 2701778

Filing Date : 2008-10-03

Strength per Unit : 60 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2028-10-03

Date Granted : 2018-09-11

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

10

Amgen Canada Inc.

CARFILZOMIB

ChemOutsourcing

Not Confirmed

Amgen Canada Inc.

Country

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-05-08

Date Granted : 2021-01-26

CARFILZOMIB

Brand Name : KYPROLIS

Patent Number : 2873044

Filing Date : 2013-05-08

Strength per Unit : 60 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2033-05-08

Date Granted : 2021-01-26

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!